Description

Clindamycin Laurate CAS NO 763863-68-9 is a specific laurate ester derivative of the lincosamide antibiotic clindamycin. This chemical intermediate is valued for its role in the synthesis of specialized pharmaceutical compounds, offering a pathway to modify the pharmacokinetic properties of the parent molecule. It is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of novel antibiotic formulations and prodrug systems.

Application

• Pharmaceutical Intermediate: Key starting material or intermediate in the synthesis of novel clindamycin analogs and prodrugs.
• Antibiotic Research: Used in microbiological and pharmacological research to study structure-activity relationships (SAR) of lincosamide antibiotics.
• Prodrug Development: Serves as a precursor in designing ester-based prodrugs aimed at improving oral bioavailability or targeted delivery.
• Chemical Reference Standard: Employed as a high-purity standard in analytical laboratories for quality control and method development.
• Veterinary Pharmaceutical Synthesis: Potential use in developing antimicrobial formulations for veterinary applications.

Basic Information

Product Name	Clindamycin Laurate
CAS No.	763863-68-9
Molecular Formula	C30H58ClN2O5S
Molecular Weight	594.31 g/mol
Synonyms	Clindamycin Dodecanoate; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxylic acid dodecanoate ester; Clindamycin Laurate Ester; Lauric Acid Clindamycin Ester; 7(S)-Chloro-7-deoxylincomycin 2-laurate
EINECS	Contact for details

Quality Control

Our Clindamycin Laurate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including identification by spectroscopic methods (IR, NMR), purity assay by HPLC, and control of related substances and residual solvents. Certificates of Analysis (COA) are provided and can be tailored to meet specific research or GMP guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Unknown Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.